The governance of imported 2019-nCov infections: What can be learned from China’s experience?

被引:0
|
作者
Hao Li
Jiaxin He
Jiayu Chen
Shuning Pan
Jiehan Feng
Shuang Liu
机构
[1] Wuhan University,Global Health Institute/School of Public Health
[2] Henan University,School of Law
[3] Shenzhen Health Development Research and Data Management Center,Institute of International Law
[4] Wuhan University,Law School
[5] Tianjin University,undefined
来源
Global Health Research and Policy | / 7卷
关键词
2019-nCoV; COVID-19; Imported infection; Policy implication; China;
D O I
暂无
中图分类号
学科分类号
摘要
Delta and Omicron variants of 2019-nCoV are still spreading globally, and many imported infections have been identified in China as well. In order to control the spread chain from imported to local, China has implemented the dynamic Covid-zero policy. In this article we summarized China’s governance models and practices of fighting potential imported infections in two directions. One targets at international travelers, which can be outlined as four lines of defense: customs epidemic prevention, quarantine upon arrival, relevant laws and regulations, and community tracking. The other is against other vectors potentially carrying 2019-nCoV, which can be outlined by three lines of defense: customs epidemic prevention, disinfection and personal protection, and information management. However, there are still some challenges that are yet to be addressed, such as illegal immigration, accidental occupational exposure to 2019-nCoV, etc. China’s experience indicates that no country can stay safe during the global pandemic as long as there are local outbreaks in other countries, and active prevention and control measures based on science and a complete set of laws and regulations are still necessary at current stage. What’s more, accountable government commitment and leadership, strengthened health and social governance systems, and whole society participation are required. It is suggested that the global community continue to closely cooperate together and take active rather than passive actions to block the potential imported 2019-nCoV from causing local spreading.
引用
收藏
相关论文
共 34 条
  • [1] The governance of imported 2019-nCov infections: What can be learned from China's experience?
    Li, Hao
    He, Jiaxin
    Chen, Jiayu
    Pan, Shuning
    Feng, Jiehan
    Liu, Shuang
    GLOBAL HEALTH RESEARCH AND POLICY, 2022, 7 (01)
  • [2] Lessons learned from the 2019-nCoV epidemic on prevention of future infectious diseases
    Pan, Xingchen
    Ojcius, David M.
    Gao, Tianyue
    Li, Zhongsheng
    Pan, Chunhua
    Pan, Chungen
    MICROBES AND INFECTION, 2020, 22 (02) : 86 - 91
  • [3] What is the status of nucleic acid contamination in 2019-nCOV vaccination sites? Can it be avoided?
    Li, Zhanjie
    Zhang, Baiyan
    Wu, Xinhua
    Yang, Min
    Zhang, Qi
    Xiang, Guohua
    Chen, Yongxin
    Zeng, Lin
    Tayier, Dilirena
    Zhang, Weihong
    Song, Ninghong
    EPIDEMIOLOGY AND INFECTION, 2021, 149
  • [4] Passengers' destinations from China: low risk of Novel Coronavirus (2019-nCoV) transmission into Africa and South America
    Haider, Najmul
    Yavlinsky, Alexei
    Simons, David
    Osman, Abdinasir Yusuf
    Ntoumi, Francine
    Zumla, Alimuddin
    Kock, Richard
    EPIDEMIOLOGY AND INFECTION, 2020, 148
  • [5] From H1N1 to 2019-nCoV, what do we learn?
    Liu Gui-E
    Tian Yuan
    Zhao Wen-Jun
    Song Shuang-Ming
    Li Lei
    State Key Laboratory of Trauma
    中华创伤杂志英文版, 2020, 23 (04) : 187 - 189
  • [6] From H1N1 to 2019-nCoV, what do we learn?
    Liu, Gui-E
    Tian, Yuan
    Zhao, Wen-Jun
    Song, Shuang-Ming
    Li, Lei
    CHINESE JOURNAL OF TRAUMATOLOGY, 2020, 23 (04) : 187 - 189
  • [7] The novel coronavirus outbreak: what can be learned from China in public reporting?
    Hao Li
    Xinguang Chen
    Hao Huang
    Global Health Research and Policy, 5
  • [8] The novel coronavirus outbreak: what can be learned from China in public reporting?
    Li, Hao
    Chen, Xinguang
    Huang, Hao
    GLOBAL HEALTH RESEARCH AND POLICY, 2020, 5 (01)
  • [9] Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections
    Schwartz, David A.
    Graham, Ashley L.
    VIRUSES-BASEL, 2020, 12 (02):
  • [10] Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV
    Morse, Jared S.
    Lalonde, Tyler
    Xu, Shiqing
    Liu, Wenshe Ray
    CHEMBIOCHEM, 2020, 21 (05) : 730 - 738